Overview

Rivastigmine for the Prevention of Postoperative Delirium in Patients Undergoing Cardiac Surgery

Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Rivastigmine is effective for the prevention of postoperative delirium in patients undergoing cardiac surgery.
Phase:
Phase 3
Details
Lead Sponsor:
University Hospital, Basel, Switzerland
Collaborator:
Novartis
Treatments:
Rivastigmine